Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia

This study will investigate the effects of intermittent Theta Burst Stimulation (iTBS) on natural oscillatory frequency of the dorsolateral prefrontal cortex (DLPFC) and working memory in early-course schizophrenia (EC-SCZ). Transcranial magnetic stimulation (TMS) will be used to evoke oscillatory activity, and EEG will record the responses of EC-SCZ participants. A working memory task will also be incorporated in order to determine how DLPFC natural frequency (NF) is related to working memory performance. iTBS (active or sham) will be administered, then the oscillatory activity of DLPFC and working memory performance will be reassessed. The overarching goal is to determine whether iTBS can acutely enhance the oscillatory activity of the DLPFC and to evaluate the relationship between changes in the DLPFC and working memory performance.

Participants needed: 75
Trial details
Age: 18-40Biological sex: AllType: InterventionalSponsor: Fabio FerrarelliUpdated: Aug 11, 2026Locations: 1
Eligibility criteria

ages 18-40 years [+2]

DSM intellectual developmental disorder [+12]

Status: Recruiting

Restoring Spindle and Thalamocortical Efficiency in Early-Course Schizophrenia Patients Using Auditory Stimulation

The purpose of this research is to identify differences in brain activity during sleep between health individuals and individuals with schizophrenia, schizophreniform, or schizoaffective disorder. This study will also investigate whether tones played during deep sleep can enhance specific features of sleep and whether enhancing such features is related to an improvement in cognitive performance.

Participants needed: 200
Trial details
Age: 18-40Biological sex: AllType: InterventionalSponsor: Fabio FerrarelliUpdated: Jun 4, 2026Locations: 1
Eligibility criteria

ages 18-40 years [+6]

DSM-IV intellectual disability [+10]